Authors:
Dupont, J
Bemish, RJ
McCarthy, KE
Payne, ER
Pollard, EB
Ripin, DHB
Vanderplas, BC
Watrous, RM
Citation: J. Dupont et al., Oxidation of carbamate-protected alkylhydrazines to the corresponding hydrazones under Swern conditions, TETRAHEDR L, 42(8), 2001, pp. 1453-1454
Authors:
Dupont, J
Bemish, RJ
McCarthy, KE
Payne, ER
Pollard, EB
Ripin, DHB
Vanderplas, BC
Watrous, RM
Citation: J. Dupont et al., Oxidation of carbamate-protected alkylhydrazines to the corresponding hydrazones under Swern conditions (vol 42, pg 1453, 2001), TETRAHEDR L, 42(32), 2001, pp. 5587-5587
Citation: Ke. Mccarthy, Recent advances in the design and synthesis of carbon-14 labelled pharmaceuticals from small molecule precursors, CUR PHARM D, 6(10), 2000, pp. 1057-1083
Authors:
Jones, BP
Schildknegt, K
Wright, KF
Showell, HJ
Dittami, JP
McCarthy, KE
Reiter, LA
Citation: Bp. Jones et al., The synthesis of an aminohexyl-containing analog of the chromanol leukotriene B-4 receptor antagonist CP-195543: A scaffold for the preparation of derivatized analogs, HETEROCYCLE, 53(8), 2000, pp. 1713
Authors:
Meyers, MO
Anthony, LB
McCarthy, KE
Drouant, G
Maloney, TJ
Espanan, GD
Woltering, EA
Citation: Mo. Meyers et al., High-dose indium In-111 pentetreotide radiotherapy for metastatic atypicalcarcinoid tumor, SOUTH MED J, 93(8), 2000, pp. 809-811
Authors:
Harrison, LH
Schwarzenberger, PO
Byrne, PS
Marrogi, AJ
Kolls, JK
McCarthy, KE
Citation: Lh. Harrison et al., Gene-modified PA1-STK cells home to tumor sites in patients with malignantpleural mesothelioma, ANN THORAC, 70(2), 2000, pp. 407-411